What Is a Mandibular Advancement Device, and Should You Be Using One?

A mandibular advancement device (MAD) is a custom-fitted oral appliance worn during sleep that holds your lower jaw (mandible) in a protruded position. By moving the jaw forward, the device tightens the muscles and soft tissue lining the back of the throat, reducing the tendency for the airway to collapse or narrow during sleep.

MADs look similar to athletic mouth guards, but they are designed differently. Most consist of upper and lower trays connected by a hardware mechanism that allows precise adjustment of how far forward the lower tray positions the jaw. This adjustability, called titration, is what separates a professionally fabricated MAD from an over-the-counter snore guard.

MADs were originally developed as an alternative for patients with sleep apnea who could not tolerate CPAP (continuous positive airway pressure) therapy. Over time, evidence has also established their effectiveness for simple snoring without apnea, and they are now a recognized first-line treatment option for mild to moderate obstructive sleep apnea (OSA).

Snoring and obstructive sleep apnea share a common mechanism: the soft tissue structures of the upper airway (the soft palate, uvula, tongue base, and pharyngeal walls) relax during sleep and partially or fully obstruct airflow. When airflow is restricted but not fully stopped, the tissue vibrates and produces snoring. When the airway collapses completely, breathing stops temporarily, and that is an apnea event.

The forward jaw position created by a MAD tightens the palatoglossal and palatopharyngeal arches and moves the tongue forward away from the posterior pharyngeal wall. The result is a more patent (open) airway with less tendency to collapse. Research shows that appropriately titrated MADs reduce the apnea-hypopnea index (AHI, the measure of apnea severity) by 50 percent or more in many patients.

Effectiveness varies by anatomy. Patients with retrognathia (a jaw that sits farther back than average) tend to respond best to MADs because their anatomy creates a naturally narrowed airway that protrusion effectively opens. Patients with obesity-related OSA (where excess tissue mass is the primary narrowing mechanism) respond less predictably.

Mild to moderate OSA (AHI of 5 to 30 events per hour) is the primary indication. The American Academy of Sleep Medicine recognizes MAD therapy as appropriate for patients with mild to moderate OSA who prefer oral appliances over CPAP, and for those who cannot tolerate or adhere to CPAP. Severe OSA (AHI above 30) may still warrant a MAD trial, particularly if CPAP adherence has failed, but CPAP remains the higher-efficacy option for severe disease.

Simple snoring without confirmed apnea is a reasonable indication when snoring is disruptive and other causes (nasal congestion, alcohol use, sleep position) have been addressed or are not applicable. A MAD can reduce snoring intensity even if no apnea is present.

Anatomic considerations matter. Patients need enough tooth structure to support the upper and lower trays, and sufficient jaw protrusive range (the ability to move the jaw forward from its resting position) to allow therapeutic advancement. Active periodontal disease or loose teeth can limit device wear because the tray attachments place lateral force on the teeth. TMJ health should be evaluated before delivery.

Children with snoring or sleep-disordered breathing are generally not candidates for MADs because jaw growth is ongoing. Pediatric sleep-disordered breathing has its own evaluation and treatment pathway.

Adherence is the most clinically meaningful advantage of MADs over CPAP. Studies consistently show that patients use their MAD more hours per night and more nights per week than CPAP. Because sleep apnea risk is cumulative across hours of untreated airway obstruction, an appliance that is used all night every night often produces better real-world outcomes than a technically more effective device that is abandoned by 2 a.m.

Portability and convenience are practical advantages. A MAD requires no power source, no mask, no tubing, and no humidity settings. It fits in a case smaller than a phone charger. This matters for travelers and for people whose sleeping environments vary.

Reduced bed partner disruption from snoring has a quality-of-life impact that is hard to overstate. For many patients, the primary goal is not managing medical risk but addressing an interpersonal problem that is affecting sleep quality for everyone in the household.

For confirmed OSA, cardiovascular benefits from adequate treatment are substantial: reduced blood pressure, lower atrial fibrillation risk, improved insulin sensitivity, and better daytime cognitive function. These benefits apply to MAD therapy when it achieves adequate AHI reduction, comparable to CPAP.

Bite changes are the most common long-term side effect. Months of nightly mandibular advancement can shift how your teeth come together. The lower front teeth tend to tip forward and the upper front teeth backward over time, reducing the horizontal overlap (overjet). These changes are usually subtle, often reversible with morning repositioning exercises, but in some patients they become permanent. Periodic dental monitoring catches this early.

TMJ strain is a real risk, particularly in patients with pre-existing disc displacement, condylar arthritis, or co-occurring bruxism. The forward condyle position imposed by the MAD changes the loading geometry on the disc and retrodiscal tissue. Patients who develop morning jaw pain, new clicking, or restricted opening after starting MAD therapy need joint evaluation before continuing.

Tooth mobility and root stress can develop if the device places excessive lateral force on teeth with compromised periodontal support. This is a reason to treat active gum disease before delivering a MAD.

Over-the-counter MAD alternatives marketed as snore guards are often less effective and harder to control. The advancement level is not calibrated, the fit is imprecise, and there is no titration pathway. For patients with diagnosed OSA, only custom-fitted devices from a trained provider should be used, as inadequate AHI reduction from an OTC device can create a false sense of security about a real medical condition.

The process starts with a sleep study to confirm whether OSA is present and assess severity. If you have already had a sleep study, bring those results. A dentist fitting a MAD needs to know whether you are treating confirmed apnea or simple snoring, because the clinical standards are different.

A dental evaluation assesses tooth and periodontal health, measures how far you can protrude your jaw, and evaluates the TMJ. Digital impressions or physical molds of your upper and lower teeth are taken, and a bite registration is recorded to establish the starting protrusion position.

The custom device is fabricated (usually takes one to two weeks) and then delivered with instructions for wear and adjustment. Titration begins by wearing at the initial setting for one to two weeks, then advancing in small increments based on symptom response. Most patients find their optimal position after four to eight weeks of titration.

A follow-up sleep study with the device in place confirms that the AHI has been reduced to acceptable levels. This step is often skipped with OTC devices and snore-guard-only approaches, which is one reason those approaches leave apnea severity unverified.